Skanska USA Building Inc. v. Regeneron Pharmaceuticals Inc.

District Court, S.D. New York·Decided July 1, 2024·No. 7:23-cv-08418·Unknown

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK SKANSKA USA BUILDING INC., Plaintiff, OPINION AND ORDER

-against- No. 23-CV-8418 (PMH) REGENERON PHARMACEUTICALS INC., Defendant. PHILIP M. HALPERN, United States District Judge: Skanska USA Building Inc. (“Skanska” or “Plaintiff”) initiated this breach of contract action against Regeneron Pharmaceuticals, Inc. (“Regeneron” or “Defendant”) on September 22, 2023. (Doc. 1, “Compl.”). The Complaint presses two claims for breach of contract, two claims for breach of the covenant of good faith and fair dealing, and one claim for declaratory judgment. (Id.). The Court issued a Civil Case Discovery Plan and Scheduling Order on December 20, 2023 (Doc. 17) and an Amended Civil Case Discovery Plan and Scheduling Order on April 8, 2024 (Doc. 38). While discovery was underway, and in accordance with the briefing schedule set by the Court, Defendant moved to dismiss the Third, Fourth, and Fifth Claims for Relief under Federal Rule of Civil Procedure 12(b)(6) on January 5, 2024. (Doc. 21; Doc. 22, “Def. Br.”; Doc. 23, “Ohring Decl.”). Plaintiff opposed on January 22, 2024 (Doc. 24, “Pl. Br.”) and the motion was fully submitted upon the filing of Defendant’s reply brief on February 5, 2024 (Doc. 25, “Reply”).1 For the reasons set forth below, Defendant’s partial motion to dismiss is GRANTED.

1 Citations to the parties’ filings correspond to the pagination generated by ECF. BACKGROUND I. The Master Services Agreement Skanska is a construction management firm with its principal place of business in Parsippany, New Jersey. (Compl. ¶¶ 5-6). Regeneron is a corporation engaged in the business of developing and manufacturing pharmaceuticals with its principal place of business in Tarrytown,

New York. (Id. ¶¶ 7-8). The parties executed a contract, the Master Service Agreement (“MSA”), which became effective on March 3, 2022. (Id. ¶ 14; Ohring Decl., Ex. A, “MSA”). Under the MSA, Skanska agreed to perform various construction management services for Regeneron in connection with new construction located at Regeneron’s campus in Tarrytown (the “Project”). (Compl. ¶¶ 1, 14). The MSA is an overarching contract that governs the parties’ respective rights and obligations with respect to the Project, and it was intended that separately negotiated Statements of Work (“SOWs”) would further define the parties’ rights, duties, and obligations with respect to the various phases and portions of work. (Id. ¶¶ 14-16). The MSA delineates two basic phases of work at the Project—the Preconstruction phase

and the Construction phase. (Id. ¶ 20). The parties intended for separate SOWs to dictate Skanska’s specific scope of work for each phase. (Id. ¶ 21). Unexecuted template SOWs were appended to the MSA as exhibits. (Id. ¶ 23). After the execution of the MSA, the parties had the ability to negotiate the terms of each specific SOW. (Id.). The MSA and related SOWs are to be construed in accordance with New York law. (Id. ¶ 17; MSA § 48.4). II. The Preconstruction Phase The parties separately negotiated and, on March 24, 2022, executed a Statement of Work with respect to the Preconstruction phase (“Precon SOW”). (Id. ¶¶ 24, 43; Ohring Decl., Ex. B, 2 “Precon SOW”). The Precon SOW contemplates three major areas for work: “Loop Road Phase 1, Loop Road Phase 2, and a pedestrian bridge connecting Loop Road Phase 1 to the buildings on Regeneron’s existing South Campus.” (Compl. ¶ 45). Preconstruction phase services included, generally: (i) assisting in the development of a Project Execution Plan; (ii) providing a critical path

Project schedule; (iii) providing budget control recommendations and construction cost estimates; (iv) reviewing the Due Diligence & Existing Conditions documentation; (v) reviewing constructability assessments; and (vi) conducting a fully coordinated bid process. (Id. ¶ 46). The MSA also provides that Skanska is entitled to compensation for any services provided during the Preconstruction phase which are requested by Regeneron and extend beyond the scope and schedule as defined by the agreements, and which are memorialized by a written Change Order. (Id. ¶¶ 35-37, 40-41, 47; MSA §§ 5.2.1(p), 34.1.1-34.1.3). Moreover, the Precon SOW set forth the duration of services for the Preconstruction phase as well as specified milestone event dates. (Compl. ¶ 50; Precon SOW § 8). Per the process set forth in the Precon SOW, Skanska could not proceed to the next section of work until an

“authorization to proceed with bidding and negotiation” or “ATP” was issued for the preceding milestone. (Compl. ¶¶ 51-52, 57-58). The Precon SOW was executed as a lump sum agreement in the amount of $6,576,465. (Id. ¶ 44; Precon SOW § 2). In early June 2022, Regeneron requested additional services from Skanska that were outside the scope of the originally contracted services under the MSA and Precon SOW (“Additional Services”) and which “caused delays, inefficiencies and other impacts to Skanska’s work during the Preconstruction Phase.” (Compl. ¶¶ 62-63, 66, 69-72). The Complaint alleges that Regeneron “failed to issue a Change Order for the Additional Services, to acknowledge financial responsibility for these services, or to pay for any portion of these services.” (Id. ¶ 81). 3 Additionally, Skanska alleges that it incurred significant delay and impact costs in the Preconstruction phase due to Regeneron’s mismanagement of the design portions of the Project. (Id. ¶¶ 83-84). The Complaint alleges that Regeneron has failed to acknowledge responsibility for or pay the delay and impact costs caused by its failure to timely issue ATPs or construction

drawings. (Id. ¶¶ 101-102). Skanska alleges that the delays and impacts caused by Regeneron and its failure to pay Skanska for those costs constitute material breaches of the MSA and Precon SOW, and amount to a total cost exceeding $3,000,000. (Id. ¶¶ 103-104). III. The Construction Phase Skanska and Regeneron began negotiations for the Construction phase SOWs in November 2022. (Id. ¶ 105). However, the Complaint alleges that it has become apparent that Regeneron has no intention of retaining Skanska for the Construction phase of the Project and that it was merely using Skanska’s preconstruction work to undercut Skanska’s position in the negotiation of the remaining Construction phase SOWs. (Id. ¶ 106). The negotiations regarding the Construction phase ultimately failed because, inter alia, Regeneron allegedly engaged in bad faith negotiation

tactics such as not adequately clarifying the commercial model and insisting on utilizing unrealistic construction milestones. (Id. ¶¶ 120-121, 126). Thereafter, Regeneron starting directly soliciting its own bids for a construction manager for the remaining Construction phase work. (Id. ¶ 127). This litigation followed. STANDARD OF REVIEW On a Rule 12(b)(6) motion, a court may dismiss a complaint for “failure to state a claim upon which relief can be granted.” Fed. R. Civ. P. 12(b)(6). “To survive a motion to dismiss, a complaint must contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atl. Corp. v. 4 Twombly, 550 U.S. 544, 570 (2007)).2 A claim is plausible on its face “when the ple[d] factual content allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Id. (citing Twombly, 550 U.S. at 556).

Free access — add to your briefcase to read the full text and ask questions with AI

Skanska USA Building Inc. v. Regeneron Pharmaceuticals Inc., (S.D.N.Y. 2024).

Skanska USA Building Inc. v. Regeneron Pharmaceuticals Inc. (Skanska USA Building Inc. v. Regeneron Pharmaceuticals Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Fishoff v. Coty, Inc.
634 F.3d 647 (Second Circuit, 2011)
Keene Corporation v. Joseph Fiorelli
14 F.3d 726 (Second Circuit, 1993)
Cruz v. FXDirectDealer, LLC
720 F.3d 115 (Second Circuit, 2013)
Harris v. Mills
572 F.3d 66 (Second Circuit, 2009)
Dalton v. Educational Testing Service
663 N.E.2d 289 (New York Court of Appeals, 1995)
Ferguson v. Lion Holding, Inc.
478 F. Supp. 2d 455 (S.D. New York, 2007)
IDT Corp. v. Tyco Group, S.A.R.L.
15 N.E.3d 329 (New York Court of Appeals, 2014)
National Gear & Piston, Inc. v. Cummins Power Systems, LLC
861 F. Supp. 2d 344 (S.D. New York, 2012)